人组织激肽释放酶14在卵巢上皮肿瘤的表达及临床意义
摘要
目的探讨人组织激肽释放酶14(kallikrein14)在卵巢癌组织中的表达及其临床意义。方法应用免疫组织化学sP法检测不同卵巢组织中klk14蛋白的表达。结果在不同卵巢肿瘤组织和正常卵巢组织中klk14阳性率表达不同,差异具有统计学意义,P〈0.05。klk14蛋白表达与卵巢癌患者的FIGO分期、组织学分级以及是否有淋巴结及远处转移有关,P〈O.05。结论klk14过表达与卵巢癌的发生、发展及其恶性行为有关,可能为卵巢癌预后不良的独立危险因素。
出处
《中国中医药现代远程教育》
2010年第4期173-174,共2页
Chinese Medicine Modern Distance Education of China
参考文献5
-
1寇歆馨,史惠蓉.激肽释放酶基因家族与妇科肿瘤关系的研究进展[J].中华妇产科杂志,2006,41(3):212-213. 被引量:4
-
2宋芷霜,史惠蓉.人类组织激肽释放酶基因14与卵巢癌研究进展[J].国外医学(妇产科学分册),2006,33(2):133-135. 被引量:2
-
3Fritzsche F,Gansukh T,Borgono CA,et al.Expression of human Kallikr ein 14(KLK14) in breastcancer is associated with higher tumour grad -es and positive nodal status[J].Br J cancer,2006,24:171-182.
-
4Angelopoulou K,Prassas I,Yousef GM.The canine kallikrein-related pep -tidase 14:structural characterization,alternative splicing and differential expression in mammary cancer[J].Gene,2009,446 (2):68-74.
-
5Paliouras M,Diamandis EP.Androgens act synergistically to enhance estr-ogen-induced upregulation of human tissue kallikreins 10,11,and 14 in breast cancer cells via a membrane bound androgen receptor[J].Mol On col2008 Apr,1(4):413-24.
二级参考文献39
-
1Harvey TJ,Hooper JD,Myers SA,et al.Tissue-specific expression patterns and fine mapping of the human kallikrein(KLK) locus on proximal 19q13.4.J Biol Chem,2000,275:37397-37406.
-
2Yousef GM,Diamandis EP.The new human tissue kallikrein gene family:structure,function,and association to disease.Endocr Rev,2001,22:184-204.
-
3Yousef GM,Diamandis EP.Human tissue kallikreins:a new enzymatic cascade pathway? Biol Chem,2002,383:1045-1057.
-
4Yousef GM,Diamandis EP.The new kallikrein-like gene,KLK-L2.Molecular characterization,mapping,tissue expression,and hormonal regulation.J Biol Chem,1999,274:37511-37516.
-
5Myers SA,Clements JA.Kallikrein 4(KLK4),a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line,KLE.J Clin Endocrinol Metab,2001,86:2323-2326.
-
6Yousef GM,Fracchioli S,Scorilas A,et al.Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.Am J Clin Pathol,2003,119:346-355.
-
7Yousef GM,Scorilas A,Katsaros D,et al.Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.J Clin Oncol,2003,21:3119-3126.
-
8Kurlender L,Yousef GM,Memari N,et al.Differential expression of a human kallikrein 5(KLK5) splice variant in ovarian and prostate cancer.Tumour Biol,2004,25:149-156.
-
9Yousef GM,White NM,Kurlender L,et al.The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.Tumour Biol,2004,25:221-227.
-
10Lu KH,Patterson AP,Wang L,et al.Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.Clin Cancer Res,2004,10:3291-3300.
共引文献3
-
1顾双,王青,张意茗,袁彩霞,张向宁.卵巢上皮性癌组织中激肽释放酶7及14的表达及临床意义[J].山东大学学报(医学版),2008,46(2):200-203. 被引量:6
-
2史惠蓉,王巍.卵巢上皮性癌组织中激肽释放酶14、15基因的表达及其意义[J].中华妇产科杂志,2009,44(4):300-302. 被引量:1
-
3史惠蓉,宋芷霜,张瑞涛,寇歆馨.卵巢上皮性癌组织中人组织激肽释放酶基因14的表达[J].郑州大学学报(医学版),2011,46(1):25-28. 被引量:2
-
1宋芷霜,史惠蓉.人类组织激肽释放酶基因14与卵巢癌研究进展[J].国外医学(妇产科学分册),2006,33(2):133-135. 被引量:2
-
2国芳,袁耀宗.microRNA在胃癌诊断与治疗中的研究进展[J].国际消化病杂志,2012,32(4):212-214. 被引量:1
-
3马翔宇,李新钢,赵鹏,王东海.绿色荧光蛋白在胶质瘤相关研究中的应用进展[J].中华神经外科杂志,2007,23(2):153-155. 被引量:3
-
4林晓,李昱,张雄.Beta-Catenin,APC蛋白,C-myc及CyclinD_1在卵巢上皮肿瘤中的表达及意义[J].重庆医科大学学报,2006,31(1):50-54. 被引量:7
-
5王丽,许国峰,欧阳俊,陈陆俊,徐斌,蒋敬庭,吴昌平.卵巢肿瘤中B7-H4分子的表达及临床意义[J].现代免疫学,2013,33(6):446-450. 被引量:4
-
6许翠萍,刘近春,韩德五.肠源性内毒素血症影响肝再生[J].山西医科大学学报,2007,38(2):182-184. 被引量:2
-
7邱广斌.microRNA 在胃癌中的临床应用[J].中华检验医学杂志,2014,37(9):653-656. 被引量:2
-
8田超,江国荣,周梁,刘兆国,朱智杰,郑仕中,王爱云,陆茵.间质干细胞与肿瘤的关系研究进展[J].中国药理学通报,2013,29(3):303-306. 被引量:2
-
9李际春,何玲.卵巢癌组织中Survivin的表达及其临床意义[J].宁夏医学杂志,2008,30(1):41-43. 被引量:1
-
10冯丽,李莉.整合素β3与生存素在子宫腺肌病中的表达及意义[J].中国妇产科临床杂志,2008,9(5):379-380. 被引量:5